PML in the brain: From development to degeneration

Frontiers in Oncology

Volumn 3 SEP, Issue , 2013, Pages

  Korb, Erica ^a,b   Finkbeiner, Steven ^a,b,c  

^a GLADSTONE INSTITUTES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arc; Circadian rhythms; Neocortex development; Neural progenitor cells; Neurodegeneration; PML; SCN; Synaptic plasticity

Indexed keywords

BETA INTERFERON; PROMYELOCYTIC LEUKEMIA PROTEIN;

ARTICLE; BRAIN DEVELOPMENT; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; EMBRYONAL CARCINOMA STEM CELL; HUMAN; NERVE CELL PLASTICITY; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SUPRACHIASMATIC NUCLEUS;

EID: 84891047454     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00242     Document Type: Article

References (25)

1. Ivanschitz L, De The H, Le Bras M. PML, SUMOylation, and senescence. Front Oncol (2013) 3:171. doi:10.3389/fonc.2013.00171
2. Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK. Differential roles of PML isoforms. Front Oncol (2013) 3:125. doi:10.3389/fonc.2013.00125
3. Lallemand-Breitenbach V, de The H. PML nuclear bodies. Cold Spring Harb Perspect Biol (2010) 2(5):a000661. doi:10.1101/cshperspect.a000661
4. Regad T, Bellodi C, Nicotera P, Salomoni P. The tumor suppressor PML regulates cell fate in the developing neocortex. Nat Neurosci (2009) 12(2):132-40. doi:10.1038/nn.2251
5. Lam YW, Ammerlaan W, O WS, Kroese F, Opstelten D. Cell type-and differentiation stage-dependent expression of PML domains in rat, detected by monoclonal antibody HIS55. Exp Cell Res (1995) 221(2):344-56. doi:10.1006/excr.1995.1384
6. Hsu WL, Everett RD. Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex virus type 1. J Virol (2001) 75(8):3819-31. doi:10.1128/JVI.75.8.3819-3831.2001
7. Miki T, Xu Z, Chen-Goodspeed M, Liu M, Van Oort-Jansen A, Rea MA, et al. PML regulates PER2 nuclear localization and circadian function. EMBO J (2012) 31(6):1427-39. doi:10.1038/emboj.2012.1
8. Butler K, Martinez LA, Tejada-Simon MV. Impaired cognitive function and reduced anxiety-related behavior in a promyelocytic leukemia (PML) tumor suppressor protein-deficient mouse. Genes Brain Behav (2013) 12(2):189-202. doi:10.1111/gbb.12014
9. Korb E, Wilkinson CL, Delgado RN, Lovero KL, Finkbeiner S. Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity. Nat Neurosci (2013) 16(7):874-83. doi:10.1038/nn.3429
10. Hayashi T, Sasaki C, Iwai M, Sato K, Zhang WR, Warita H, et al. Induction of PML immunoreactivity in rat brain neurons after transient middle cerebral artery occlusion. Neurol Res (2001) 23(7):772-6. doi:10.1179/016164101101199162
11. Chort A, Alves S, Marinello M, Dufresnois B, Dornbierer JG, Tesson C, et al. Interferon beta induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice. Brain (2013) 136(Pt 6):1732-45. doi:10.1093/brain/awt061
12. Takahashi J, Fujigasaki H, Iwabuchi K, Bruni AC, Uchihara T, El Hachimi KH, et al. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol Dis (2003) 13(3):230-7. doi:10.1016/S0969-9961(03)00080-9
13. Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain (2006) 129(Pt 4):853-67. doi:10.1093/brain/awh724
14. Yamada M, Sato T, Shimohata T, Hayashi S, Igarashi S, Tsuji S, et al. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol (2001) 159(5):1785-95. doi:10.1016/S0002-9440(10)63025-8
15. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A, et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature (1997) 389(6654):971-4. doi:10.1038/40153
16. Lee J, Hong YK, Jeon GS, Hwang YJ, Kim KY, Seong KH, et al. ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington's disease. Cell Death Differ (2012) 19(7):1109-16. doi:10.1038/cdd.2011.196
17. Janer A, Martin E, Muriel MP, Latouche M, Fujigasaki H, Ruberg M, et al. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. J Cell Biol (2006) 174(1):65-76. doi:10.1083/jcb.200511045
18. Salomoni P, Betts-Henderson J. The role of PML in the nervous system. Mol Neurobiol (2011) 43(2):114-23. doi:10.1007/s12035-010-8156-y
19. Bloomer WA, VanDongen HM, VanDongen AM. Activity-regulated cytoskeleton-associated protein Arc/Arg3.1 binds to spectrin and associates with nuclear promyelocytic leukemia (PML) bodies. Brain Res (2007) 1153:20-33. doi:10.1016/j.brainres.2007.03.079
20. Korb E, Finkbeiner S. Arc in synaptic plasticity: from gene to behavior. Trends Neurosci (2011) 34(11):591-8. doi:10.1016/j.tins.2011.08.007
21. Bramham CR, Alme MN, Bittins M, Kuipers SD, Nair RR, Pai B, et al. The Arc of synaptic memory. Exp Brain Res (2010) 200(2):125-40. doi:10.1007/s00221-009-1959-2
22. Michod D, Bartesaghi S, Khelifi A, Bellodi C, Berliocchi L, Nicotera P, et al. Calcium-dependent dephosphorylation of the histone chaperone DAXX regulates H3.3 loading and transcription upon neuronal activation. Neuron (2012) 74(1):122-35. doi:10.1016/j.neuron.2012.02.021
23. Wolyniec K, Carney DA, Haupt S, Haupt Y. New strategies to direct therapeutic targeting of PML to treat cancers. Front Oncol (2013) 3:124. doi:10.3389/fonc.2013.00124
24. Kida S. A functional role for CREB as a positive regulator of memory formation and LTP. Exp Neurobiol (2012) 21(4):136-40. doi:10.5607/en.2012.21.4.136
25. Barco A, Marie H. Genetic approaches to investigate the role of CREB in neuronal plasticity and memory. Mol Neurobiol (2011) 44(3):330-49. doi:10.1007/s12035-011-8209-x